Dr. Stanton is Chief of the Kidney and Hypertension Section at the Joslin Diabetes Center, a Principal Investigator (Section on Vascular Cell Biology), and an Associate Professor of Medicine at Harvard Medical School. Dr. Stanton has given many invited lectures throughout the world and written many original articles and reviews on clinical and basic science aspects of diabetic kidney disease.
Dr. Stanton’s research is focused on the essential enzyme, glucose 6-phosphate dehydrogenase (G6PD). His lab has discovered that this enzyme (and associated pathway) is essential for cell survival and dysregulation of G6PD plays an important role in the pathogenesis of many diseases. He has received honorary professorships from other universities and a major lifetime-achievement teaching award for Sustained Excellence in Teaching from Harvard Medical School.
